Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.
Identifieur interne : 003F99 ( PubMed/Corpus ); précédent : 003F98; suivant : 004000Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.
Auteurs : D D Duane ; J. Monroe ; R E MorrisSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2000.
English descriptors
- KwdEn :
- Antibody Formation (drug effects), Antibody Formation (immunology), Botulinum Toxins, Type A (administration & dosage), Botulinum Toxins, Type A (immunology), Humans, Immunosuppressive Agents (administration & dosage), Mycophenolic Acid (administration & dosage), Mycophenolic Acid (analogs & derivatives), Neutralization Tests, Premedication, Recurrence, Torticollis (drug therapy), Treatment Outcome.
- MESH :
- chemical , administration & dosage : Botulinum Toxins, Type A, Immunosuppressive Agents, Mycophenolic Acid.
- chemical , analogs & derivatives : Mycophenolic Acid.
- drug effects : Antibody Formation.
- drug therapy : Torticollis.
- immunology : Antibody Formation, Botulinum Toxins, Type A.
- Humans, Neutralization Tests, Premedication, Recurrence, Treatment Outcome.
PubMed: 10752603
Links to Exploration step
pubmed:10752603Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.</title><author><name sortKey="Duane, D D" sort="Duane, D D" uniqKey="Duane D" first="D D" last="Duane">D D Duane</name></author><author><name sortKey="Monroe, J" sort="Monroe, J" uniqKey="Monroe J" first="J" last="Monroe">J. Monroe</name></author><author><name sortKey="Morris, R E" sort="Morris, R E" uniqKey="Morris R" first="R E" last="Morris">R E Morris</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2000">2000</date><idno type="RBID">pubmed:10752603</idno><idno type="pmid">10752603</idno><idno type="wicri:Area/PubMed/Corpus">003F99</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.</title><author><name sortKey="Duane, D D" sort="Duane, D D" uniqKey="Duane D" first="D D" last="Duane">D D Duane</name></author><author><name sortKey="Monroe, J" sort="Monroe, J" uniqKey="Monroe J" first="J" last="Monroe">J. Monroe</name></author><author><name sortKey="Morris, R E" sort="Morris, R E" uniqKey="Morris R" first="R E" last="Morris">R E Morris</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="2000" type="published">2000</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibody Formation (drug effects)</term><term>Antibody Formation (immunology)</term><term>Botulinum Toxins, Type A (administration & dosage)</term><term>Botulinum Toxins, Type A (immunology)</term><term>Humans</term><term>Immunosuppressive Agents (administration & dosage)</term><term>Mycophenolic Acid (administration & dosage)</term><term>Mycophenolic Acid (analogs & derivatives)</term><term>Neutralization Tests</term><term>Premedication</term><term>Recurrence</term><term>Torticollis (drug therapy)</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Botulinum Toxins, Type A</term><term>Immunosuppressive Agents</term><term>Mycophenolic Acid</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Mycophenolic Acid</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Antibody Formation</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Torticollis</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Antibody Formation</term><term>Botulinum Toxins, Type A</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Neutralization Tests</term><term>Premedication</term><term>Recurrence</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">10752603</PMID><DateCreated><Year>2000</Year><Month>06</Month><Day>09</Day></DateCreated><DateCompleted><Year>2000</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2000</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.</ArticleTitle><Pagination><MedlinePgn>365-6</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duane</LastName><ForeName>D D</ForeName><Initials>DD</Initials></Author><Author ValidYN="Y"><LastName>Monroe</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>R E</ForeName><Initials>RE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>UNITED STATES</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9242ECW6R0</RegistryNumber><NameOfSubstance UI="C063008">mycophenolate mofetil</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.69</RegistryNumber><NameOfSubstance UI="D019274">Botulinum Toxins, Type A</NameOfSubstance></Chemical><Chemical><RegistryNumber>HU9DX48N0T</RegistryNumber><NameOfSubstance UI="D009173">Mycophenolic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000917">Antibody Formation</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName><QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D019274">Botulinum Toxins, Type A</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName><QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007166">Immunosuppressive Agents</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D009173">Mycophenolic Acid</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000031">analogs & derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D009500">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011292">Premedication</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D012008">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D014103">Torticollis</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>4</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>6</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>4</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10752603</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F99 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003F99 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:10752603
|texte= Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:10752603" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |